PEMGX
Price
$41.88
Change
+$0.26 (+0.62%)
Updated
Jan 13 closing price
Net Assets
27.95B
PMBJX
Price
$40.10
Change
+$0.24 (+0.60%)
Updated
Jan 13 closing price
Net Assets
27.95B
Ad is loading...

PEMGX vs PMBJX

Header iconPEMGX vs PMBJX Comparison
Open Charts PEMGX vs PMBJXBanner chart's image
Principal MidCap A
Price$41.88
Change+$0.26 (+0.62%)
VolumeN/A
Net Assets27.95B
Principal MidCap J
Price$40.10
Change+$0.24 (+0.60%)
VolumeN/A
Net Assets27.95B
PEMGX vs PMBJX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PEMGX vs. PMBJX commentary
Jan 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PEMGX is a Buy and PMBJX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
PEMGX (27.9B) and PMBJX (27.9B) have equal amount of cash in the bank . PEMGX (0.00) and PMBJX (0.00) have matching dividends . PEMGX was incepted earlier than PMBJX: PEMGX (20 years) vs PMBJX (24 years). PEMGX (10.10) and PMBJX (10.10) have comparable annual turnover. PEMGX (1000) and PMBJX (1000) have matching initial minimum investment requirements. PMBJX (15.17) and PEMGX (15.13) have marching annual gain over last year. PMBJX (35.80) and PEMGX (35.79) have equivalent 5 years return.
PEMGXPMBJXPEMGX / PMBJX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence20 years24 years-
Gain YTD-2.346-2.328101%
Front LoadN/AN/A-
Min. Initial Investment10001000100%
Min. Initial Investment IRAN/AN/A-
Net Assets27.9B27.9B100%
Annual Yield % from dividends0.000.00-
Returns for 1 year15.1315.17100%
Returns for 3 years8.308.4199%
Returns for 5 years35.7935.80100%
Returns for 10 years96.0395.44101%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LAES5.730.45
+8.63%
SEALSQ Corp
DUOL318.67-4.47
-1.38%
Duolingo
MRBK13.71-0.31
-2.21%
Meridian Corp
FLNC16.09-1.00
-5.85%
Fluence Energy
MTNB0.62-0.04
-6.63%
Matinas Biopharma Holdings Inc